HeartResearch Commentary13 min readApr 28, 2026

Does Extra Virgin Olive Oil Always Help Cholesterol? A Crossover Trial Says Context Matters

What happens when you add a lot of extra virgin olive oil to a diet that is already designed to lower cardiovascular risk? Not the simple answer most people expect. In a randomized crossover trial of 40 adults at elevated cardiovascular risk, a low-EVOO whole-food, plant-based phase produced the bigger LDL-C drop than a high-EVOO phase. That does not make olive oil “bad.” It does make the surrounding dietary pattern, and the dose of oil itself, impossible to ignore.

Study Overview

Paper: Recipe for Heart Health: A Randomized Crossover Trial on Cardiometabolic Effects of Extra Virgin Olive Oil Within a Whole-Food Plant-Based Vegan Diet
Journal: Journal of the American Heart Association
Authors: Andrea M. Krenek et al.
Year: 2024
DOI: 10.1161/JAHA.124.035034
Design: Randomized crossover trial with weekly cooking classes
Sample size: 40 participants
Eligibility: Adults with at least 5% cardiovascular disease risk
Intervention: 4 tablespoons/day EVOO vs <1 teaspoon/day EVOO
Duration: 4 weeks per phase, 1-week washout

This is not a vague “olive oil is healthy” paper. It is a tightly framed test of dose and context. The investigators used linear mixed models, adjusted for age, sex, and body-weight change, and looked at LDL-C as the primary endpoint. That matters because the whole-food plant-based diet itself is already a strong lipid-lowering intervention. The real question is whether a lot more EVOO adds benefit, does nothing, or quietly weakens the lipid response.

Key Findings: The Numbers That Matter

40
Adults completed the crossover
Enough to see a signal, not enough to settle the whole debate.
48% vs 32%
Energy from fat during high- vs low-EVOO phases
The higher-oil phase materially changed the macronutrient mix.
Δ -12.7 mg/dL
LDL-C change in the high-to-low sequence
Mean±SEM 12.7(5.9), P = 0.04 when moving from high to low EVOO.
Δ +15.8 mg/dL
LDL-C change in the low-to-high sequence
Mean±SEM 15.8(6.8), P = 0.02, showing a clear order effect.

The headline sounds almost backwards: both diets improved cardiometabolic markers, but the low-EVOO phase produced more pronounced LDL-C reduction. In the first period, LDL-C fell by 25.5(5.1) mg/dL after the low-EVOO phase versus 16.7(4.2) mg/dL after the high-EVOO phase, although that difference did not hit conventional significance (P = 0.162). Across the whole trial, the investigators also reported reductions in total cholesterol, apolipoprotein B, glucose, and high-sensitivity C-reactive protein, with all of those within-phase changes reaching P < 0.05.

There is one more detail worth sitting with: the sequence mattered. That usually means diet studies are closer to physiology than to ideology. Biology remembers what you ate before. If the first phase is already very low in oil, the second phase may behave differently because the system has been shifted.

Mechanism: Why Might More EVOO Blunt LDL Lowering?

1. The low-oil phase may simply be the lower-calorie, lower-fat lever

LDL-C often improves when saturated fat falls and the overall diet becomes less energy-dense. A whole-food plant-based pattern already pushes in that direction. If you then add 4 tablespoons of EVOO, you are not adding a neutral fluid, you are adding a meaningful fat load that changes the macronutrient balance.

2. EVOO’s polyphenols may help, but dose and matrix still matter

Extra virgin olive oil contains hydroxytyrosol, oleocanthal, oleacein, and related phenolics that can improve oxidative stress and endothelial biology. But this trial was not a polyphenol-standardized capsule study. It was a real-food dietary pattern trial. That means the effect is the sum of the oil’s chemistry, its calories, and the rest of the plate.

3. Short-term LDL kinetics may react faster than people expect

In only 4 weeks per phase, lipid changes are mostly about acute dietary composition. That makes the study useful, because it captures the near-term effect that most people actually see on a follow-up lipid panel. It also means the result is about short-term physiology, not lifelong event risk.

Context: Does This Contradict the Bigger Olive Oil Story?

Not really. It refines it. The strongest cardiovascular olive oil data still come from Mediterranean-pattern studies where EVOO replaces worse fats, not where it is layered onto an already optimized low-oil intervention. PREDIMED-style evidence supports EVOO as a cardioprotective food inside a broader Mediterranean diet. This trial asks a narrower question: if the rest of the diet is already very protective, does adding a lot more EVOO keep pushing LDL lower? Here, the answer is not obviously yes.

That distinction matters for health-conscious readers. A food can be beneficial in one context and merely neutral, or slightly counterproductive for a specific biomarker, in another. Olive oil is not magic. It is a high-quality fat with a real polyphenol payload. But a low-oil whole-food plant-based diet and a Mediterranean diet are not interchangeable, and the intervention you choose should match the outcome you care about.

The most honest reading is probably this: EVOO remains a smart fat, but it is not automatically the best lever for lowering LDL-C once the diet is already engineered for that job.

Practical Takeaway

  • • If your main goal is LDL reduction, the whole diet matters more than a single bottle of olive oil.
  • • EVOO still makes sense when it replaces inferior fats, but “more” is not always “better.”
  • • If you are already eating a low-oil, high-fiber diet, monitor lipids before assuming extra oil will help.
  • • The smartest use of EVOO is targeted, not reflexive, especially when calorie control is part of the plan.

Limitations

Small sample

Forty participants is enough for a signal, not enough for a universal rule.

Short duration

Four weeks per phase tells us about short-term biomarker shifts, not long-term events.

Sequence effects complicate interpretation

The order interaction is interesting, but it means the comparison is not perfectly clean.

No phenolic biomarker standardization

The paper does not prove whether a smaller amount of higher-polyphenol EVOO would behave differently.

Our Take

This is a strong little paper because it asks a real-world question with a real diet, not a lab fantasy. It is also a useful warning against lazy nutrition storytelling. People like to say EVOO is heart-healthy, full stop. The better answer is: yes, usually, but only in the right context and at the right dose.

I would not use this trial to tell people to avoid EVOO. I would use it to tell them not to confuse a high-quality fat with a universal lipid-lowering tool. If your diet is already optimized for LDL reduction, adding four tablespoons a day of oil may not buy you anything, and may buy you slightly less than a lower-oil version of the same pattern.

Bottom line: EVOO is still a premium fat. It is just not exempt from dose-response biology.

References

1. Krenek AM, Mathews A, Guo J, Courville AB, Pepine CJ, Chung ST, Aggarwal M. Recipe for Heart Health: A Randomized Crossover Trial on Cardiometabolic Effects of Extra Virgin Olive Oil Within a Whole-Food Plant-Based Vegan Diet. Journal of the American Heart Association. 2024;13(15). doi:10.1161/JAHA.124.035034. Paper →

2. ClinicalTrials.gov registration: NCT04828447. Trial registry →

Want olive oils that earn their keep?

Look for freshness, high polyphenols, and a dietary pattern that actually matches your goal.

See the rankings →